0001593968-23-000097.txt : 20230109
0001593968-23-000097.hdr.sgml : 20230109
20230109162420
ACCESSION NUMBER: 0001593968-23-000097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230105
FILED AS OF DATE: 20230109
DATE AS OF CHANGE: 20230109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOSTER ANDREW B
CENTRAL INDEX KEY: 0001285221
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36475
FILM NUMBER: 23518404
BUSINESS ADDRESS:
STREET 1: 440 CLYDE AVE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 6509305282
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEMETIS, INC
CENTRAL INDEX KEY: 0000738214
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 261407544
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20400 STEVENS CREEK BLVD
STREET 2: SUITE 700
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 408-517-3304
MAIL ADDRESS:
STREET 1: 20400 STEVENS CREEK BLVD
STREET 2: SUITE 700
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: AE BIOFUELS, INC.
DATE OF NAME CHANGE: 20110714
FORMER COMPANY:
FORMER CONFORMED NAME: AE Biofuels, Inc.
DATE OF NAME CHANGE: 20071212
FORMER COMPANY:
FORMER CONFORMED NAME: MARWICH II LTD
DATE OF NAME CHANGE: 19840123
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2023-01-05
0000738214
AEMETIS, INC
AMTX
0001285221
FOSTER ANDREW B
20400 STEVENS CREK BLVD, SUITE 700
CUPERTINO
CA
95014
false
true
false
false
Executive Vice President
Option (right to buy)
3.75
2023-01-05
4
A
false
12500
3.75
A
2023-04-05
2033-01-05
Common stock and Series B Preferred
12500
12500
D
Option (right to buy)
3.75
2023-01-05
4
A
false
137500
3.75
A
2023-04-05
2033-01-05
Common stock and Series B Preferred
137500
137500
D
1/12th of the Option Shares vest every three(3)months from the date of the grant.
Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.75 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. The grant was split into 137,500 non-qualified Incentive stock options (NQSO) and 12,500 as Incentive Stock Options (ISO) under the IRC 422(d) adjustment.
/s/Todd Waltz attorney-infact
2023-01-09